Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Medipost
DescriptionAllogeneic mesenchymal stem cells from umbilical cord blood
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase II
Standard IndicationBronchopulmonary dysplasia (BPD)
Indication DetailsTreat bronchopulmonary dysplasia (BPD) in premature infants
Regulatory Designation U.S. - Orphan Drug (Treat bronchopulmonary dysplasia (BPD) in premature infants)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today